A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma

BACKGROUND: Ixabepilone (BMS-247550), an epothilone B analog, is a microtubule stabilizing agent which has shown activity in several different tumor types and preclinical models in melanoma. In an open label, one-arm, multi-center phase II trial the efficacy and toxicity of this epothilone was inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Ott, Patrick A., Hamilton, Anne, Jones, Amanda, Haas, Naomi, Shore, Tsiporah, Liddell, Sandra, Christos, Paul J., Doyle, L. Austin, Millward, Michael, Muggia, Franco M., Pavlick, Anna C.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808339/
https://www.ncbi.nlm.nih.gov/pubmed/20098694
http://dx.doi.org/10.1371/journal.pone.0008714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808339/
https://www.ncbi.nlm.nih.gov/pubmed/20098694
http://dx.doi.org/10.1371/journal.pone.0008714

Ejemplares similares